We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve GOV.UK Sign up to take part in user research (opens in a new tab)
Updated safety advice has been issued to strengthen warnings about potential psychiatric and sexual dysfunction linked to finasteride and to provide precautionary advice on dutasteride.
To future-proof the sector and ensure regulation keeps up with scientific and technological developments, the MHRA is consulting on proposed changes to how gene therapies are defined in UK legislation.
New pre-market regulatory requirements for medical devices and in vitro diagnostic devices entering the GB market have been published.
The MHRA continues to speed up access to medicines for patients, increase efficiency of regulation and help to attract innovation and investment in the UK’s thriving £100 billion life sciences industry.
Infected Blood Compensation Authority's update that was circulated on 07 May, 2026
MHRA approves donidalorsen (Dawnzera) for the treatment of hereditary angioedema
MHRA and UK Border Force crack down on the illegal medicines trade in intensive 14-day international operation.
A statement from the Foreign Secretary on the Hantavirus outbreak
First published during the 2024 to 2026 Starmer Labour government
An evaluation of how NHS public information supports decision-making about screening tests in pregnancy
As with all medicines, we will continue to closely monitor the safety and effectiveness of linerixibat as it is used more widely.
The government has confirmed it will provide a grant for new electric ambulances to replace those destroyed in arson attack.
Secretary of State delivers a speech on NHS urgent and emergency care at Royal College of Emergency Medicine's (RCEM) annual conference in Birmingham.
The MHRA has limited the use of nasal decongestant sprays containing xylometazoline and oxymetazoline to a maximum of five days due to side effects of prolonged use.
Thousands more therapists, psychiatrists and mental health nurses are working in the health service.
The Medicines and Healthcare products Regulatory Agency (MHRA) is pleased to announce the appointment of Jason Bonander as its new Chief Digital and Technology Officer (CDTO).
The next generation will be smoke-free as Tobacco and Vapes Bill is granted Royal Assent.
An MHRA-led investigation has exposed a £1.8 million illegal medicines and steroids network, leading to seven men being sentenced.
Training tackles harmful assumptions about disability and ensures staff make practical, meaningful adjustments for the people they serve.
The MHRA has advised healthcare professionals to stop supplying the affected batch of Sertraline 100mg and return all remaining stock to their suppliers.
Patients in the UK to get access to new treatments faster and still safely under new clinical trial regulations coming into force on 28 April 2026.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).